Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,949
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,732
Class I recallsReasonable probability of serious health consequences
24,263
Class II recallsTemporary or medically reversible health consequences
2,873
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,071 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,458 recalls have been announced year to date.
  • Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1

Showing 221–240 of 22,519 recalls

FDA Recall Ongoing 2026 recordClass II

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30

by Ascend Laboratories, LLC

Reason
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

Gas-X Extra Strength, SIMETHICONE 125 mg/ANTIGAS, packaged in a) 120 SoftGels (UPC 3 00674 35041 9, b) 72 SoftGels (UPC 3 00439 00572 1), Distributed by: Haleon, Warren, NJ 07059.

by Haleon US Holdings LLC

Reason
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Zep, Alcohol Sanitizer Spray, Ethanol 70%, Net Contents 55 Gallons 208 Liters, Made in USA, A Zep Inc. Brand, Distributed by: Zap Inc., 350 Joe Frank Harris Parkway, SE, Emerson, GA 30137, NDC 66949-133-85.

by Zep Inc

Reason
Microbial contamination of sterile products
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 53746-544-01

by Amneal Pharmaceuticals, LLC

Reason
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Duloxetine Delayed-Release Capsules, USP, 60mg, packaged in a) 90 Capsules (NDC 51991-748-90); b) 1000 Capsules (51991-748-10), Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)

by Fresenius Kabi USA, LLC

Reason
Failed Impurities/Degradations Specifications
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Presence of Particulate matter: Particulate matter identified as glass.
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

SENSORY SUPPLEMENT LLC

Product
NEURO NOURISH dietary supplement; 6-IN-1 PREBIOTIC, PROBIOTI…
Reason
Premature lipid oxidation causing quality issue potentially causing product to have an off odor and bitter taste.
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

BEF Foods, Inc

Product
Park St. Deli Macaroni & Cheese, NET WT 20 OZ (1 LB 4 OZ) 56…
Reason
Undeclared allergen (soy lecithin).
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

U.S. Tov, Inc. dba U.S. Trading Company

Product
DRAGONFLY Thai Ginger Powder Net Weight: 4.37 oz (125 g) PRO…
Reason
Potential contamination with lead.
Published
June 17, 2026
Distribution
Domestic: AK, AR, CA, CO, FL, IA, ID, IL…

View recall →

FDA Recall United States Ongoing 2026 recordClass I

Total Nutrition Inc

Product
1. TNVitamins Ultrapotent Complete Green Superfood Moringa C…
Reason
Product may be contaminated with Salmonella.
Published
June 17, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

Rich Products Corp

Product
Farm Rich Pizza Cheese Crunchers
Reason
May contain metal pieces
Published
June 17, 2026
Distribution
Multiple states

View recall →

FDA Recall Ongoing 2026 recordClass II

Xyvona (levorphanol tartrate tablets), 3mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Fort Bio-Pharma, LLC., Las Vegas, NV 89113, NDC 72245-058-10

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Fort Bio-Pharma, LLC., Las Vegas, NV 89113, NDC 72245-762-10

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

by Lannett Company Inc.

Reason
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TopCare health, ULTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 1000mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY TOPCO ASSOCIATES LLC.,ELK GROVE VILLAGE, IL 60007, NDC 76162-129-68.

by Guardian Drug Co. Inc.

Reason
Presence of foreign substance: small metallic particles in chewable tablets.
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TopCare health, EXTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 750mg, 96 CHEWABLE TABLETS, DISTRIBUTED BY TOPCO ASSOCIATES LLC.,ELK GROVE VILLAGE, IL 60007, NDC 76162-128-22.

by Guardian Drug Co. Inc.

Reason
Presence of foreign substance: small metallic particles in chewable tablets.
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

EQUALINE ultra strength, antacid tablets, calcium carbonate 1000mg, 72 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-171-68.

by Guardian Drug Co. Inc.

Reason
Presence of foreign substance: small metallic particles in chewable tablets.
Published
June 10, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

EQUALINE extra strength, antacid tablets, calcium carbonate 750mg, 96 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-129-22.

by Guardian Drug Co. Inc.

Reason
Presence of foreign substance: small metallic particles in chewable tablets.
Published
June 10, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.